Clinical Trial Update: An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic studies of cabotegravir (GSK1265744) in healthy adults, examining recovery, excretion, and pharmacokinetics after a single oral dose and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-associated Lipodystrophy Syndrome

Drugs mentioned

• cabotegravir (cabotegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV-associated Lipodystrophy Syndrome | Phase 1 | Status: COMPLETED